MELISSA LAGRANGE: Open Payments
NPI 1508403304 · PERRYSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 91 payments from 16 companies in 2025. Trend: 2023 $1,040 · 2024 $1,217 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $367 |
| AstraZeneca Pharmaceuticals LP | 8 | $209 |
| PFIZER INC. | 12 | $204 |
| Novo Nordisk Inc | 13 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $155 |
| Exact Sciences Corporation | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Lundbeck LLC | 1 | $26 |
| UCB, Inc. | 1 | $24 |
Products named: CAPLYTA, Ozempic, QULIPTA, VRAYLAR, NURTEC ODT, FARXIGA, Cologuard Collection Kit, LINZESS.
Industry payments across OH — which companies pay providers there.
